|Articles|July 3, 1996
Immunomedics makes $10 million placement
Monoclonal antibody imaging agent developer Immunomedics of MorrisPlains, NJ, announced last week that it has sold $10 million inconvertible preferred stock to international investors. The investorscan convert the stock into shares of common stock over
Advertisement
Monoclonal antibody imaging agent developer Immunomedics of Morris
Plains, NJ, announced last week that it has sold $10 million in
convertible preferred stock to international investors. The investors
can convert the stock into shares of common stock over the next
two years.
Advertisement
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
Mammography Study Shows Impact of AI-Powered Slab Reconstruction with DBT
2
GE HealthCare Unveils 4D Dynamic PET Imaging Software at SNMMI Conference
3
FDA Clears AI Ultrasound Software for Automated LVEF Calculation
4
Can AI Assessment of CT Attenuation Correction Mapping Be a Viable Alternative for CAC Risk Stratification?
5











